Appropriateness of vancomycin therapeutic drug monitoring and its outcomes among non-dialysis patients in a tertiary hospital in Singapore

Int J Clin Pharm. 2018 Oct;40(5):977-981. doi: 10.1007/s11096-018-0670-4. Epub 2018 Jun 12.

Abstract

Background Vancomycin therapeutic drug monitoring (TDM) is commonly performed to ensure safe and effective use of the antibiotic. Aim of Study To evaluate appropriateness of vancomycin TDM and its outcomes in Singapore General Hospital. Method A retrospective, cross-sectional study was conducted between 1 January 2014 and 28 February 2014 involving patients who received ≥ 1 dose of intravenous vancomycin with TDM. Patient demographics and relevant vancomycin TDM data were collected from medical records. Results Of 746 vancomycin troughs measured among 234 patients, 459 troughs (61.5%) were taken inappropriately, with a median time of 2.6 h (interquartile range 1.1-4.3) before the next scheduled dose. Inappropriate interpretation of vancomycin troughs resulted in 41 unnecessary dose suspensions, 24 dose changes, and 102 unchanged vancomycin doses. The cost incurred due to inappropriate interpretation and measurement after discontinuation of treatment was US$7286. No differences in rates of vancomycin related nephrotoxicity, ototoxicity, recurrent infection, development of infection secondary to vancomycin resistant microorganism and mortality were observed (p > 0.05). Conclusion This study highlighted a high incidence of inappropriate vancomycin TDM which has led to increased healthcare cost.

Keywords: Dosing; Outcomes; Singapore; Therapeutic drug monitoring; Timing; Vancomycin.

MeSH terms

  • Administration, Intravenous
  • Adult
  • Aged
  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / blood*
  • Anti-Bacterial Agents / economics
  • Drug Monitoring / economics
  • Drug Monitoring / methods*
  • Drug Monitoring / standards
  • Humans
  • Middle Aged
  • Retrospective Studies
  • Singapore / epidemiology
  • Tertiary Care Centers* / economics
  • Tertiary Care Centers* / standards
  • Treatment Outcome
  • Vancomycin / administration & dosage*
  • Vancomycin / blood*
  • Vancomycin / economics

Substances

  • Anti-Bacterial Agents
  • Vancomycin